{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65701",
      "recalling_firm": "Sanofi US",
      "address_1": "55 Corporate Dr",
      "address_2": "N/A",
      "postal_code": "08807-1265",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-841-2013",
      "product_description": "Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30",
      "product_quantity": "2,462 bottles",
      "reason_for_recall": "Subpotent drug: low fill volume in some of the capsules",
      "recall_initiation_date": "20130307",
      "center_classification_date": "20130805",
      "termination_date": "20140317",
      "report_date": "20130814",
      "code_info": "Lot # 3097657,  Exp 3/15"
    }
  ]
}